Patents by Inventor Michael Foote

Michael Foote has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10301267
    Abstract: There is provided a compound of formula (I): or a pharmaceutically acceptable salt thereof. There are also provided processes for the manufacture of a compound of Formula 1, and the use of a compound of Formula 1 as a medicament and in the treatment of cancer.
    Type: Grant
    Filed: May 26, 2017
    Date of Patent: May 28, 2019
    Assignee: AstraZeneca AB
    Inventors: David Buttar, Kevin Michael Foote, Maria-Elena Theoclitou, Andrew Peter Thomas
  • Patent number: 10038939
    Abstract: A system and method for enabling a user to interact with a social networking structure for an internet website on a video device connected to a network enabled host device is provided. The present disclosure provides for accessing an internet site in response to a user input, the user input initiated while outputting a program to a display, retrieving content from the internet site based on at least one characteristic associated with the program, and outputting the retrieved content in an overlay or user interface on the display simultaneous with the program. The user interface provides the ability to access multiple profiles for determining whose content or message to display, and also includes a rotating carousel message display system, with a current message surrounded above and below by a previous message and a next message in the display queue in a different size or font.
    Type: Grant
    Filed: March 27, 2014
    Date of Patent: July 31, 2018
    Assignee: THOMSON LICENSING
    Inventors: Evan Michael Foote, Martin Vincent Davey
  • Patent number: 9688640
    Abstract: There is provided a compound of formula (I): or a pharmaceutically acceptable salt thereof. There are also provided processes for the manufacture of a compound of Formula 1, and the use of a compound of Formula 1 as a medicament and in the treatment of cancer.
    Type: Grant
    Filed: June 26, 2015
    Date of Patent: June 27, 2017
    Assignee: ASTRAZENECA AB
    Inventors: David Buttar, Kevin Michael Foote, Maria-Elena Theoclitou, Andrew Peter Thomas
  • Patent number: 9596518
    Abstract: A system and method for enabling a user to display and interact with a social networking structure on a video device connected to a network enabled host device is provided. A user interface (UI) is also provided for displaying content (e.g. messages or tweets) that is output in an overlay for display on a display while program video is playing. The method provides for accessing a social networking site in response to a user input, the user input initiated while outputting a program for display, generating at least one keyword for searching the social networking site based on at least one characteristic associated with the program, retrieving content from the social networking site based the at least one keyword and outputting the retrieved content in an overlay for display simultaneous with the program.
    Type: Grant
    Filed: March 26, 2015
    Date of Patent: March 14, 2017
    Assignee: THOMSON LICENSING
    Inventors: Evan Michael Foote, Martin Vincent Davey
  • Patent number: 9421213
    Abstract: There is provided pyrimidinyl compounds of Formula (I), wherein: R2 is or pharmaceutically acceptable salts thereof, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Grant
    Filed: September 21, 2015
    Date of Patent: August 23, 2016
    Assignee: AstraZeneca AB
    Inventors: Kevin Michael Foote, Johannes Wilhelmus Maria Nissink, Paul Turner
  • Publication number: 20160074412
    Abstract: There is provided pyrimidinyl compounds of Formula (I), wherein: R2 is or pharmaceutically acceptable salts thereof, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: September 21, 2015
    Publication date: March 17, 2016
    Applicant: AstraZeneca AB
    Inventors: Kevin Michael Foote, Johannes Wilhelmus, Maria Nissink, Paul Turner
  • Publication number: 20150295913
    Abstract: A method for enhanced login is described including determining if a user is attempting to login to a particular account, performing analysis on the user's passwords if the user is not attempting to login to the particular account, determining if it is time to change a password on the particular account, if the user is attempting to login to the particular account, suggesting alternative passwords to the user based on the password analysis and performing a login procedure.
    Type: Application
    Filed: November 14, 2012
    Publication date: October 15, 2015
    Inventors: Evan Michael Foote, Mark Anthony Mayhew, Benjamin Thomas Vondersaar
  • Patent number: 9155742
    Abstract: There is provided pyrimidinyl compounds of Formula (I), wherein: R2 is or pharmaceutically acceptable salts thereof, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Grant
    Filed: February 26, 2015
    Date of Patent: October 13, 2015
    Assignee: AstraZeneca AB
    Inventors: Kevin Michael Foote, Johannes Wilhelmus Maria Nissink, Paul Turner
  • Patent number: 9088766
    Abstract: The marking of a video stream to impart a unique identifier commences by first identifying portions within the video stream readily susceptible to change in a visually imperceptible manner. Thereafter, a combination of visually imperceptible changes is applied to the identified portions at random intervals for randomly varying intervals to mark the video stream. Each change in the stream correlates a particular bit sequence so that a combination of different changes yields a string of bit sequences that can particularly identify the stream.
    Type: Grant
    Filed: March 25, 2011
    Date of Patent: July 21, 2015
    Inventor: Evan Michael Foote
  • Publication number: 20150201243
    Abstract: A system and method for enabling a user to display and interact with a social networking structure on a video device connected to a network enabled host device is provided. A user interface (UI) is also provided for displaying content (e.g. messages or tweets) that is output in an overlay for display on a display while program video is playing. The method provides for accessing a social networking site in response to a user input, the user input initiated while outputting a program for display, generating at least one keyword for searching the social networking site based on at least one characteristic associated with the program, retrieving content from the social networking site based the at least one keyword and outputting the retrieved content in an overlay for display simultaneous with the program.
    Type: Application
    Filed: March 26, 2015
    Publication date: July 16, 2015
    Inventors: Evan Michael Foote, Martin Vincent Davey
  • Patent number: 9075983
    Abstract: A more secure CAPTCHA makes use of a distorted alphanumeric character string or strings that include one or more glyphs, pictures or symbols foreign to a target audience. Adding at least one of a glyph, picture or symbol makes recognition of the distorted string trivial since humans who would know which of the character set to expect, but a very difficult decision for a computer already struggling to decide where a character begins and ends, let alone identifying the character as being valid.
    Type: Grant
    Filed: May 26, 2011
    Date of Patent: July 7, 2015
    Assignee: Thomson Licensing
    Inventor: Evan Michael Foote
  • Publication number: 20150164908
    Abstract: There is provided pyrimidinyl compounds of Formula (I), wherein: R2 is or pharmaceutically acceptable salts thereof, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: February 26, 2015
    Publication date: June 18, 2015
    Applicant: AstraZeneca AB
    Inventors: Kevin Michael Foote, Johannes Wilhelmus, Maria Nissink, Paul Turner
  • Patent number: 9058414
    Abstract: A method and system to remotely control data logging are described including establishing a first connection, transmitting a signal to initiate data logging, terminating the established first connection, initializing a timer, determining if the timer has expired, establishing a second connection, transmitting a signal to cease data logging, transmitting a signal to collect the logged data and receiving the logged data.
    Type: Grant
    Filed: November 20, 2012
    Date of Patent: June 16, 2015
    Assignee: THOMSON LICENSING
    Inventor: Evan Michael Foote
  • Patent number: 9009758
    Abstract: A system and method for enabling a user to display and interact with a social networking structure on a video device connected to a network enabled host device is provided. A user interface (UI) 700 is also provided for displaying content (e.g. messages or tweets) that is output in an overlay for display on a display while program video is playing. The method provides for accessing a social networking site in response to a user input, the user input initiated while outputting a program for display, generating at least one keyword for searching the social networking site based on at least one characteristic associated with the program, retrieving content from the social networking site based the at least one keyword and outputting the retrieved content in an overlay for display simultaneous with the program.
    Type: Grant
    Filed: August 3, 2010
    Date of Patent: April 14, 2015
    Assignee: Thomson Licensing, LLC
    Inventors: Evan Michael Foote, Martin Vincent Davey
  • Publication number: 20140337883
    Abstract: A method and apparatus for exchanging media content consumption characteristics in a network is described. The method includes receiving input data, the input data indicating that a first user in a user group has changed a content consumption characteristic, determining if the first user's changed content consumption characteristic is based a content consumption characteristic of a second user in the user group, and generating a message, the message including information indicating that the first user's changed content consumption characteristic is based on the content consumption characteristic of the second user in the user group. The apparatus includes a transceiver circuit that is coupled to the network and a controller circuit that receives input data from the first user, further determines if the first user's change is based on input data received through the transceiver circuit from the second user, and further generates the message that is provided.
    Type: Application
    Filed: December 13, 2011
    Publication date: November 13, 2014
    Applicant: Thomson Licensing
    Inventor: Evan Michael Foote
  • Publication number: 20140331258
    Abstract: A method and apparatus for allowing users in a user group to interact and exchange media content characteristics in a network as a part of the entertainment experience is described. The method and apparatus include identifying a group of users from a plurality of users in a network, detecting a change in at least one content consumption characteristic by a first user, the content consumption characteristic associated with the first user consuming media content, providing information related to the change in the least one content consumption characteristic to other users in the identified group, detecting a change in at least one content consumption characteristic by a second user in the group of users, the change based on the information related to the change by the first user, and providing information related to the change by the second user to the other users in the identified group.
    Type: Application
    Filed: December 13, 2011
    Publication date: November 6, 2014
    Applicant: Thomson Licensing
    Inventor: Evan Michael Foote
  • Patent number: 8789099
    Abstract: An electronic program guide includes a plurality of elements arrayed in a grid of rows and columns, with the rows corresponding to program sources and the columns corresponding to time intervals. Each element corresponds to a program played out from a particular program source during a corresponding time interval. The background of each element changes, such as by way of a color gradient or changing shape, to indicate one of a program beginning or ending. In this way, a viewer can ascertain the length of the program even if the element gets clipped upon updating the electronic program guide.
    Type: Grant
    Filed: January 25, 2011
    Date of Patent: July 22, 2014
    Assignee: Thomson Licensing
    Inventor: Evan Michael Foote
  • Publication number: 20140143609
    Abstract: A method and system to remotely control data logging are described including establishing a first connection, transmitting a signal to initiate data logging, terminating the established first connection, initializing a timer, determining if the timer has expired, establishing a second connection, transmitting a signal to cease data logging, transmitting a signal to collect the logged data and receiving the logged data.
    Type: Application
    Filed: November 20, 2012
    Publication date: May 22, 2014
    Applicant: THOMSON LICENSING
    Inventor: Evan Michael Foote
  • Publication number: 20130347090
    Abstract: A more secure CAPTCHA makes use of a distorted alphanumeric character string or strings that include one or more glyphs, pictures or symbols foreign to a target audience. Adding at least one of a glyph, picture or symbol makes recognition of the distorted string trivial since humans who would know which of the character set to expect, but a very difficult decision for a computer already struggling to decide where a character begins and ends, let alone identifying the character as being valid.
    Type: Application
    Filed: May 26, 2011
    Publication date: December 26, 2013
    Inventor: Evan Michael Foote
  • Patent number: 8604022
    Abstract: There is provided a compound of formula (I): or a pharmaceutically acceptable salt thereof. There are also provided processes for the manufacture of a compound of Formula 1, and the use of a compound of Formula 1 as a medicament and in the treatment of cancer.
    Type: Grant
    Filed: January 26, 2012
    Date of Patent: December 10, 2013
    Assignee: AstraZeneca AB
    Inventors: Kevin Michael Foote, Maria-Elena Theoclitou, Andrew Peter Thomas, David Buttar